Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines
US11046657B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 13, 2017 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Aug 25, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A subject of the present invention is a compound having the general formula (I): Another subject of the invention is the compound as defined above for use as a medicament, in particular for preventing and/or treating inflammation and inflammatory diseases, immune and auto-immune diseases, pain related diseases, genetic diseases and/or cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.